These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9180277)

  • 1. Regulation of the DNA binding of p53 by its interaction with protein kinase CK2.
    Prowald A; Schuster N; Montenarh M
    FEBS Lett; 1997 May; 408(1):99-104. PubMed ID: 9180277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
    Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
    Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2.
    Schuster N; Prowald A; Schneider E; Scheidtmann KH; Montenarh M
    FEBS Lett; 1999 Mar; 447(2-3):160-6. PubMed ID: 10214938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta-subunit of protein kinase CK2.
    Appel K; Wagner P; Boldyreff B; Issinger OG; Montenarh M
    Oncogene; 1995 Nov; 11(10):1971-8. PubMed ID: 7478515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casein kinase 2 inhibits the renaturation of complementary DNA strands mediated by p53 protein.
    Filhol O; Baudier J; Chambaz EM; Cochet C
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):331-5. PubMed ID: 8645226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type p53 inhibits protein kinase CK2 activity.
    Schuster N; Götz C; Faust M; Schneider E; Prowald A; Jungbluth A; Montenarh M
    J Cell Biochem; 2001; 81(1):172-83. PubMed ID: 11180407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.
    McKendrick L; Milne D; Meek D
    Mol Cell Biochem; 1999 Jan; 191(1-2):187-99. PubMed ID: 10094408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L; Meek DW
    Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of protein kinase CK2 protein subunits and p53 in F9 teratocarcinoma cells in the absence and presence of cisplatin.
    Küpper M; Köster M; Schmidt-Spaniol I; Wagner-Gillen I; Issinger OG
    Cell Mol Biol Res; 1994; 40(5-6):587-92. PubMed ID: 7735333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation.
    Guerra B; Götz C; Wagner P; Montenarh M; Issinger OG
    Oncogene; 1997 Jun; 14(22):2683-8. PubMed ID: 9178766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin H is a new binding partner for protein kinase CK2.
    Faust M; Kartarius S; Schwindling SL; Montenarh M
    Biochem Biophys Res Commun; 2002 Aug; 296(1):13-9. PubMed ID: 12147220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase CK2 interacts with a multi-protein binding domain of p53.
    Götz C; Scholtes P; Prowald A; Schuster N; Nastainczyk W; Montenarh M
    Mol Cell Biochem; 1999 Jan; 191(1-2):111-20. PubMed ID: 10094399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group.
    Hansen S; Hupp TR; Lane DP
    J Biol Chem; 1996 Feb; 271(7):3917-24. PubMed ID: 8632013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a CK2 phosphorylation site in mdm2.
    Götz C; Kartarius S; Scholtes P; Nastainczyk W; Montenarh M
    Eur J Biochem; 1999 Dec; 266(2):493-501. PubMed ID: 10561590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.
    Hupp TR; Lane DP
    Cold Spring Harb Symp Quant Biol; 1994; 59():195-206. PubMed ID: 7587070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site.
    Blaydes JP; Hupp TR
    Oncogene; 1998 Aug; 17(8):1045-52. PubMed ID: 9747884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casein kinase II and the tumor suppressor protein P53 associate in a molecular complex that is negatively regulated upon P53 phosphorylation.
    Filhol O; Baudier J; Delphin C; Loue-Mackenbach P; Chambaz EM; Cochet C
    J Biol Chem; 1992 Oct; 267(29):20577-83. PubMed ID: 1400378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, expression and properties of the alpha' subunit of casein kinase 2 from zebrafish (Danio rerio).
    Antonelli M; Daniotti JL; Rojo D; Allende CC; Allende JE
    Eur J Biochem; 1996 Oct; 241(1):272-9. PubMed ID: 8898916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
    Rolley N; Milner J
    Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 'regulatory' beta-subunit of protein kinase CK2 negatively influences p53-mediated allosteric effects on Chk2 activation.
    Bjørling-Poulsen M; Siehler S; Wiesmüller L; Meek D; Niefind K; Issinger OG
    Oncogene; 2005 Sep; 24(40):6194-200. PubMed ID: 15940255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.